Iqvia Holdings Inc (IQV)

May 27, 2025

IQVIA Holdings Inc (IQV) Trading 3.28% Higher on May 27 - GuruFocus

May 27, 2025

May 27, 2025

IQVIA Holdings Inc. Announces First Patient Dosed in Renew Phase 2 Trial of Lti-03 in Patients with Ipf - marketscreener.com

May 27, 2025

May 27, 2025

IQV Collaborates with Rein Therapeutics on New IPF Trial | IQV S - GuruFocus

May 27, 2025

May 27, 2025

IQV Collaborates with Rein Therapeutics on New IPF Trial | IQV Stock News - GuruFocus

May 27, 2025

May 27, 2025

Rein Therapeutics Announces First Patient Dosed in RENEW Phase 2 Trial of LTI-03 in Patients with IPF - marketscreener.com

May 27, 2025

May 25, 2025

IQVIA’s SWOT analysis: healthcare data giant faces industry headwinds - Investing.com Australia

May 25, 2025

May 25, 2025

IQVIA’s SWOT analysis: healthcare data giant faces industry headwinds By Investing.com - Investing.com Nigeria

May 25, 2025

May 23, 2025

IQVIA Gears Up to Report Q1 Earnings: What's in Store for the Stock? - MSN

May 23, 2025

May 23, 2025

IQVIA (IQV) Projects Global Cancer Drug Spending to Hit $441B by 2029 - GuruFocus

May 23, 2025

May 23, 2025

(IQV) Trading Advice - news.stocktradersdaily.com

May 23, 2025

May 22, 2025

IQV: Cautious Outlook Amidst Delayed Decisions | IQV Stock News - GuruFocus

May 22, 2025

May 22, 2025

IQVIA Holdings Inc (IQV) Stock Price Down 3.4% on May 21 - GuruFocus

May 22, 2025

May 21, 2025

IQVIA Stock: Is Wall Street Bullish or Bearish? - Barchart.com

May 21, 2025

May 19, 2025

IQVIA (IQV) Stock Sees Analyst Target Price Adjustment by JP Mor - GuruFocus

May 19, 2025

May 19, 2025

IQVIA (IQV) Stock Sees Analyst Target Price Adjustment by JP Morgan | IQV Stock News - GuruFocus

May 19, 2025

May 19, 2025

IQV Q1 Earnings Call: Real-World Evidence Drives Outperformance Amid Sector Uncertainty - Yahoo Finance

May 19, 2025

May 16, 2025

IQVIA Holdings (NYSE:IQV) Partners With SCRI Innovations To Enhance Global Oncology Trials - Yahoo

May 16, 2025

May 16, 2025

IQVIA and SCRI Collaborate to Accelerate Global Oncology Trials - marketscreener.com

May 16, 2025

May 16, 2025

IQVIA Teams Up With SCRI to Expedite Development of New Cancer Therapies - marketscreener.com

May 16, 2025

May 16, 2025

IQVIA And SCRI Collaborate To Accelerate Global Oncology Trials - marketscreener.com

May 16, 2025

May 15, 2025

Is IQVIA Holdings Inc. (IQV) The Most Undervalued Stock With Smart Money Ratings? - Insider Monkey

May 15, 2025

May 15, 2025

Deep Dive Into IQVIA Hldgs Stock: Analyst Perspectives (10 Ratings) - Benzinga

May 15, 2025

May 15, 2025

IQVIA Holdings (IQV): Analyst Maintains Rating, Lowers Price Tar - GuruFocus

May 15, 2025

May 15, 2025

IQVIA Holdings (IQV): Analyst Maintains Rating, Lowers Price Target | IQV Stock News - GuruFocus

May 15, 2025

May 15, 2025

Mizuho Adjusts Price Target for Iqvia (IQV) to $190 | IQV Stock News - GuruFocus

May 15, 2025

May 15, 2025

Mizuho Adjusts Price Target on IQVIA Holdings to $190 From $210, Maintains Outperform Rating - marketscreener.com

May 15, 2025

May 14, 2025

IQVIA Holdings Inc. stock underperforms Wednesday when compared to competitors - MarketWatch

May 14, 2025

May 14, 2025

Questex’s Fierce Biotech Announces 2025 Fierce CRO Award Finalists - GlobeNewswire Inc.

May 14, 2025

May 14, 2025

Positive Outlook for IQVIA Holdings Driven by Resilient TAS, Strategic Capital Allocation, and R&D Strength - TipRanks

May 14, 2025

May 13, 2025

IQVIA Holdings Inc. (NYSE:IQV) Q1 2025 Earnings Call Transcript - MSN

May 13, 2025

May 13, 2025

IQVIA at BofA Securities 2025: Strong Q1 Amid Market Challenges By Investing.com - Investing.com Nigeria

May 13, 2025

May 13, 2025

IQVIA at BofA Securities 2025: Strong Q1 Amid Market Challenges - Investing.com

May 13, 2025

May 13, 2025

Investing in IQVIA (IQV)? Don't Miss Assessing Its International Revenue Trends - Yahoo Finance

May 13, 2025

May 12, 2025

(IQV) Investment Analysis and Advice - news.stocktradersdaily.com

May 12, 2025

May 10, 2025

IQVIA Holdings (IQV) Surpasses Q1 Earnings and Revenue Estimates - MSN

May 10, 2025

May 09, 2025

IQVIA: Q1 Earnings Support Steady Optimism (NYSE:IQV) - Seeking Alpha

May 09, 2025

May 08, 2025

IQVIA raises 2025 revenue guidance amid strong TAS growth and expanded AI deployment - MSN

May 08, 2025

May 08, 2025

Morgan Stanley Adjusts Price Target on IQVIA Holdings to $185 From $250, Maintains Overweight Rating - marketscreener.com

May 08, 2025

May 08, 2025

Truist Financial Sticks to Its Buy Rating for IQVIA Holdings (IQV) - The Globe and Mail

May 08, 2025

May 07, 2025

IQVIA Ups Revenue Forecast After Exceeding Profit Estimates - Finimize

May 07, 2025

May 07, 2025

IQVIA Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch

May 07, 2025

May 07, 2025

IQVIA CFO Ron Bruehlman to speak at the Bank of America Annual Health Care Conference on May 13 - Business Wire

May 07, 2025

May 07, 2025

Barclays Lowers IQVIA Holdings (IQV) Price Target to $165 Amid Demand Concerns | IQV stock price - paginasiete.bo

May 07, 2025

May 07, 2025

IQVIA (IQV) Target Price Lowered by UBS, Rating Maintained | IQV Stock News - GuruFocus

May 07, 2025

May 07, 2025

IQVIA Holdings (IQV): Barclays Lowers Price Target to $165 | IQV Stock News - GuruFocus

May 07, 2025

May 07, 2025

Stephens Adjusts Price Target on IQVIA Holdings to $200 From $250, Maintains Overweight Rating - marketscreener.com

May 07, 2025

May 07, 2025

Citigroup Adjusts Price Target on IQVIA Holdings to $160 From $210, Maintains Neutral Rating - marketscreener.com

May 07, 2025

May 07, 2025

Baird Adjusts Price Target on IQVIA Holdings to $161 From $195, Maintains Neutral Rating - marketscreener.com

May 07, 2025

May 07, 2025

Barclays Adjusts Iqvia (IQV) Price Target Amid Demand Concerns | IQV Stock News - GuruFocus

May 07, 2025